Greenwood, Rosemary

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., Greenwood, R., Sikaroodi, M., Lam, V., Crotty, P., et al. (2013) · Clinical Gastroenterology and Hepatology

Gut microbiota and healthLiver Disease Diagnosis and Treatment

Cited by 672

Psychological well‐being in patients on ‘adequate’ doses of l‐thyroxine: results of a large, controlled community‐based questionnaire study

Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 514

Falling Threshold for Treatment of Borderline Elevated Thyrotropin Levels—Balancing Benefits and Risks: Evidence From a Large Community-Based Study

Taylor, P. N., Iqbal, A., Minassian, C., Sayers, A., Draman, M. S., Greenwood, R., Hamilton, W., Okosieme, O., Panicker, V., Thomas, S. L., et al. (2014) · JAMA Internal Medicine

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 300

Partial Substitution of Thyroxine (T4) with Tri-Iodothyronine in Patients on T4Replacement Therapy: Results of a Large Community-Based Randomized Controlled Trial

Saravanan, P., Simmons, D. J., Greenwood, R., Peters, T. J., & Dayan, C. M. (2005) · The Journal of Clinical Endocrinology & Metabolism

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 136

O-Glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines

Patsos, G., Hebbe-Viton, V., Robbe-Masselot, C., Masselot, D., Martin, R. S., Greenwood, R., Paraskeva, C., Klein, A., Graessmann, M., Michalski, J. C., et al. (2009) · Glycobiology

Glycosylation and Glycoproteins ResearchCarbohydrate Chemistry and Synthesis

Cited by 68